U.S. Marine and Shipping Stock News

NYSE:MAS
NYSE:MASBuilding

Masco (MAS) Valuation Check After FTSE All World Index Removal And Recent Selling Pressure

Index removal puts Masco in focus Masco (MAS) was recently removed from the FTSE All-World Index (USD). This type of event can prompt mechanical selling by index-tracking funds and bring short term trading pressures onto the stock. See our latest analysis for Masco. At a share price of US$60.19, Masco has had a 1 month share price return of 18.53% decline and a 1 year total shareholder return of 12.96% decline. However, the 3 year total shareholder return of 31.17% suggests longer term...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics Challenges Short Report As Valuation And Compliance Scrutinized

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...
NasdaqGM:GDS
NasdaqGM:GDSIT

GDS Holdings (NasdaqGM:GDS) Valuation After Earnings Show Revenue Growth But Weaker Profitability And 2026 Outlook

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Is It Too Late To Consider Arcellx (ACLX) After Its Strong 81% YTD Rally?

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

A Look At Carlyle Group (CG) Valuation After Recent Share Price Weakness

Why Carlyle Group Stock Is On Investors’ Radar Carlyle Group (CG) has drawn fresh attention after a period of weaker share performance, with the stock declining about 8% over the past month and roughly 23% over the past 3 months. At a last close of US$46.77, the firm carries a market value of about US$16.98b, supported by reported revenue of US$4,031.6m and net income of US$808.7m across its global investment platform. See our latest analysis for Carlyle Group. The recent 1 month share price...
NYSE:ARLO
NYSE:ARLOElectronic

The Bull Case For Arlo Technologies (ARLO) Could Change Following Upside Revenue Surprise And Profitability Inflection – Learn Why

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Assessing 10x Genomics (TXG) Valuation After STELA Partnership And Ongoing Cathie Wood Buying

Why 10x Genomics Is Back in Focus 10x Genomics (TXG) is back on investor watchlists after two catalysts: its role in Bioptimus’ new STELA spatial tissue atlas, and steady share purchases by high profile fund manager Cathie Wood. See our latest analysis for 10x Genomics. The recent partnership on the STELA initiative and continued buying from Cathie Wood have arrived while the share price sits at US$20.43, with a 90 day share price return of 23.89% and a 1 year total shareholder return of...
NYSE:HMN
NYSE:HMNInsurance

Undervalued Small Caps With Insider Action Across Regions

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.
NYSE:KVYO
NYSE:KVYOSoftware

Exploring High Growth Tech Stocks In The US Market March 2026

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.
NYSE:PRG
NYSE:PRGConsumer Finance

Is PROG Holdings (PRG) Priced Attractive After Recent Share Price Weakness?

Wondering whether PROG Holdings at around US$29.02 actually offers value, or if the recent share price leaves limited upside? This breakdown helps you frame that question with numbers, not guesswork. The stock is up 3.8% over the last week, sits at a 21.7% decline over 30 days, and is around 1.2% lower year to date. The 1 year and 3 year returns are 7.7% and 33.6%, and the 5 year return is a 33.8% decline. Recent headlines around PROG Holdings have focused on its position within the broader...
NYSE:ABBV
NYSE:ABBVBiotechs

3 Stocks That May Be Underestimated In March 2026

Over the last 7 days, the United States market has experienced a 1.6% decline, yet it has shown resilience with a 15% rise over the past year and an anticipated earnings growth of 16% annually in the coming years. In this environment, identifying stocks that may be underestimated requires looking beyond short-term fluctuations to find companies with strong fundamentals and potential for long-term value appreciation.
NYSE:APO
NYSE:APODiversified Financial

Is Apollo Global Management (APO) Attractive After Recent Share Price Weakness?

Wondering if Apollo Global Management at around US$109.98 is offering good value, or if the market is asking too much for the stock right now. The share price has seen a 1.2% decline over the last week and 3.6% over the past month, set against a 25.0% decline year to date and a 21.4% decline over the last year. The 3 year and 5 year returns sit at 88.1% and 154.6% respectively. Recent headlines around Apollo Global Management have focused on its role as a major diversified financial player...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Discover Precigen And 2 Other Insider-Favored Growth Stocks

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may offer potential opportunities for investors seeking alignment of interests.
NYSE:SSB
NYSE:SSBBanks

SouthState Bank Buyback Plan And Upgrade Reframe Capital Return Story

SouthState Bank (NYSE:SSB) announces a new share repurchase plan approved by its board. The company pairs the buyback authorization with CEO comments pointing to strong business performance. An analyst upgrade follows, signaling increased confidence in SouthState Bank's outlook. SouthState Bank, a regional banking franchise listed on the NYSE under the ticker SSB, operates in a sector that has been closely watched for capital returns, credit quality and funding costs. A fresh share...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

March 2026's Promising Penny Stocks To Watch

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.
NYSE:OII
NYSE:OIIEnergy Services

Assessing Oceaneering International (OII) Valuation After Strong Recent Share Price Momentum

Why Oceaneering International (OII) Is On Investors’ Radar Today Recent performance in Oceaneering International (OII) has caught investor attention, with the stock showing a mix of strong past 3 months and 1 year total returns alongside a weaker month. Against that backdrop, the company’s US$2.8b in revenue and US$353.8m in net income, spread across offshore energy and defense related segments, provide a broad based business to assess beyond short term share price moves. See our latest...
NYSE:ASIX
NYSE:ASIXChemicals

Discovering US Undiscovered Gems In March 2026

Over the last 7 days, the United States market has experienced a slight dip of 1.6%, yet it remains robust with a 15% increase over the past year and anticipated earnings growth of 16% per annum in the coming years. In this dynamic environment, identifying stocks that are undervalued or overlooked can provide unique opportunities for investors seeking to capitalize on emerging potential within a thriving market.
NasdaqGS:JJSF
NasdaqGS:JJSFFood

Top Dividend Stocks Including J&J Snack Foods For Your Portfolio

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has seen a notable increase of 15% over the past year, with earnings expected to grow by 16% annually. In this dynamic environment, selecting dividend stocks that offer both stability and growth potential can be an effective strategy for investors seeking reliable income streams and long-term value.